Zenocutuzumab Shows Clinical Benefit in Rare Bile Duct Cancer
BOSTON – Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led...
BOSTON – Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led...
Patients with brain metastasis experienced responses in the phase I clinical trial BOSTON – Zocilurtatug pelitecan (zoci), also known as ZL-1310, an...
PHILADELPHIA – The American Association for Cancer Research (AACR) extends its sincerest congratulations to the nine AACR members who...
Epigenetic therapy boosted immunotherapy response in refractory natural killer/T-cell lymphoma by turning cold tumors hot PHILADELPHIA – Combining an...
SAN ANTONIO – Armando E. Giuliano, MD, will receive the William L. McGuire Memorial Lecture Award during the 2025...
Certain cancer patients in U.S. states that expanded Medicaid experienced increased survival, especially in rural and high-poverty regions PHILADELPHIA...
SAN DIEGO – The American Association for Cancer Research (AACR) will award the 22nd AACR-Irving Weinstein Foundation Distinguished Lectureship...
Patients diagnosed with abnormal breast cells were more likely to receive a later diagnosis of breast cancer if their...
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Anthony G. Letai, MD, PhD, on his appointment...
Social risks include insecure access to living essentials and affordable health care, as well as psychological issues BALTIMORE –...